A 2847 – New Jersey
Introduced: 2020 Status: Inactive / Dead
Establishes pilot program for incentive-based value payment system for home health agencies and health care service firms.
A 2849 – New Jersey
Introduced: 2020 Status: Inactive / Dead
Establishes pilot program for incentive-based value payment system for nursing homes.
A 2861 – New York
Introduced: 2023 Status: In Process
Requires the commissioner of health to include in annual reports information regarding the cost and increase in cost of the ten prescription drugs on which the state expends the most money and which have had …
A 2864 (see companion bill S 1043) – New Jersey
Introduced: 2022 Status: In Process
This bill establishes the Office of Health Transformation in the Department of the Treasury. The office would serve strategic planning, advisory, coordination, communication, and contract review and development functions to drive improvement in State healthcare …
A 289 (see companion bill S 2121) – New York
Introduced: 2021 Status: In Process
Relates to enhancing coverage and care for medically fragile children; requires that health plans adopt policies and procedures tailored to the unique healthcare needs of this population.
A 291 (see companion bill S 1768) – New York
Introduced: 2021 Status: In Process
Relates to reducing pharmacy benefit manager costs; defines “pharmacy benefit manager”.
A 2939 – New York
Introduced: 2017 Status: Inactive / Dead
PRESCRIPTION DRUG COST TRANSPARENCY: Requires drug manufacturers selling medications in NY with a WAC of $1,000 for a 30 day supply and/or for which the price has increased more than three times the consumer price …
A 298 (see companion bill S 2134) – New York
Introduced: 2017 Status: Inactive / Dead
Expands health insurance coverage of physical and occupational therapy services by limiting co-payments and regulating visit limitations; expands coverage of early intervention services; expands utilization review of health insurance coverage for medically necessary care
A 3 (see companion bill S 3) – New Jersey
Introduced: 2023 Status: Enacted
Revises income eligibility criteria for PAAD and Senior Gold Prescription Discount Program
A 3007 (see companion bill S 2007) – New York
Introduced: 2017 Status: Enacted
HEALTH AND MENTAL HEALTH BUDGET: Establishes a Medicaid drug cap. Providers for Medicaid DUR Board to follow a recommendation for a target supplemental Medicaid rebate to be paid by the manufacturer of the drug to …
A 3007C – New York
Introduced: 2021 Status: Enacted
Enacts into law major components of legislation necessary to implement the state health and mental hygiene budget for the 2021-2022 state fiscal year; extends the medicaid global cap; requires a quarterly report on certain medicaid …
A 3007C (see companion bill S 4007C) – New York
Introduced: 2023 Status: Enacted
Requires notice of “material transactions” between “health care entities” be provided to the state’s health department at least 30 days before the transaction’s closing date. A material transaction is defined as any of the following …
A 3020 (see companion bill S 2237) – New York
Introduced: 2023 Status: In Process
Provides for coverage for certain individuals under the 1332 state innovation program.
A 3049 (see companion bill S 234) – New Jersey
Introduced: 2020 Status: Inactive / Dead
Establishes prescription drug pricing disclosure requirements and measures to reduce prescription drug costs.
A 3057 (see companion bill S 1028) – New Jersey
Introduced: 2018 Status: Inactive / Dead
Establishes Office of Health Transformation to coordinate certain strategic planning for State health care programs. The Office of Health Transformation shall serve strategic planning, advisory, coordination, communication, and contract review and development functions in its …
A 3063 (see companion S 2212) – New Jersey
Introduced: 2020 Status: Inactive / Dead
“Prescription Drug Consumer Transparency Act.”